# Commission Implementing Decision of 8 August 2012 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (notified under document C(2012) 5538) (Text with EEA relevance) (2012/506/EU), Division: Clinical breakpoints are presented as S≤x mg/L; I>x, ≤y mg/L; R>y mg/L

Extent: E+W+S+N.I.

Microorganisms and corresponding antimicrobial agents (bug-drug combinations) relevant for surveillance in humans are defined in the relevant surveillance protocols

---
Source: https://www.legislation.gov.uk/eudn/2012/506/annex/division/3/division/3.2/division/5 (the official version)
Page: https://openlegislation.uk/eu-decision-2012-506/annex/division-3/division-3.2/division-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.